Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “obesity”
- Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese PatientsNot Yet Recruiting
Sponsor: Yunlong Wang
Atrial Fibrillation · Obesity & Overweight · Catheter Ablation
- A Phase I Study of Single and Multiple Doses of HS-20136-2 Injection in Healthy or Obese ParticipantsNot Yet Recruiting
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Obesity
China
Sponsor: Novo Nordisk A/S
Obesity
United States
- Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)Not Yet Recruiting
Sponsor: West China Hospital
Metabolic Dysfunction-Associated Steatohepatitis · Hepatic Steatosis · Living Liver Donors
China
Sponsor: University Hospital, Clermont-Ferrand
Pediatric Obesity
France
- Effect of Thoracic Mobilization in People With Central ObesityNot Yet Recruiting
Sponsor: Cairo University
Central Obesity · Ventilatory Function
Sponsor: Amgen
Overweight and Obesity
United States
Sponsor: John Bauer
Obesity and Overweight · Obese Adolescents · Weight Management · Weight Loss
United States
Sponsor: University of Colorado, Denver
Infertility, Female · Obesity
United States
Sponsor: Hatice Zehra FERHATLAR
Obesity · Sarcopenia · Bariatric Surgery
Turkey (Türkiye)
- Effectiveness of a Care Model for Sarcopenic Obesity in Older Adults on Fat Mass, Muscle Mass, Muscle Strength, and Physical PerformanceEnrolling By Invitation
Sponsor: Srinakharinwirot University
Sarcopenic Obesity
Thailand
- A Study to Evaluate the Safety of Exposure to Wegovy During PregnancyEnrolling By Invitation
Sponsor: Novo Nordisk A/S
Pregnancy · Obesity · Overweight
United States
- AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose WeightNot Yet Recruiting
Sponsor: Novo Nordisk A/S
Obesity · Overweight
India, Japan, Malaysia, South Korea, Thailand
Sponsor: Maastricht University Medical Center
Healthy · Overweight (BMI > 25) · Overweight , Obesity · Male
Netherlands
Sponsor: Tufts University
Obesity & Overweight · Weight Management
United States
Sponsor: Hoffmann-La Roche
Obesity or Overweight
United States, Argentina, Australia, Belgium, Brazil +14 more
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)Active Not Recruiting
Sponsor: Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD) · Chronic Kidney Disease (CKD)
United States, Argentina, Australia, Austria, Belgium +22 more
Sponsor: Eli Lilly and Company
Obesity · Overweight
United States, Argentina
- A Study in Participants With Obesity or Overweight With at Least One Weight-related ComorbidityCompleted
Sponsor: AstraZeneca
Obesity or Overweight
United States, Australia, Canada, Japan, United Kingdom
- Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or ObesityActive Not Recruiting
Sponsor: Amgen
Overweight · Obesity
United States
- A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have ObesityActive Not Recruiting
Sponsor: Eli Lilly and Company
Obesity
United States, Argentina, Germany, Poland, Puerto Rico
- Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal WomenEnrolling By Invitation
Sponsor: Mayo Clinic
Obesity · Menopause
United States
- Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive InterventionsActive Not Recruiting
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Weight Loss
United States
Sponsor: Eli Lilly and Company
Obesity
Japan
- E-Bike Commuting and Health in Overweight College StudentsActive Not Recruiting
Sponsor: University of Wisconsin, River Falls
Obesity &Amp; Overweight · Sedentary Behaviors · Cardiometabolic Risk · Physical Inactivity
United States